Issued Patents All Time
Showing 26–50 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9581597 | Myeloperoxidase, a risk indicator for cardiovascular disease | Renliang Zhang | 2017-02-28 |
| 9575065 | Myeloperoxidase, a risk indicator for cardiovascular disease | Renliang Zhang | 2017-02-21 |
| 9541620 | NMR quantification of TMAO | James D. Otvos, Elias J. Jeyarajah, Justyna E. Wolak-Dinsmore, Thomas M. O'Connell, Dennis W. Bennett +1 more | 2017-01-10 |
| 9522950 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Jonathan Smith | 2016-12-20 |
| 9435808 | Myeloperoxidase, a risk indicator for cardiovascular disease | Renliang Zhang | 2016-09-06 |
| 9423405 | Trimethylamine compounds as risk predictors of cardiovascular disease | Zeneng Wang, Bruce S. Levison | 2016-08-23 |
| 9410938 | Biomarkers for asthma | Suzy Comhair, Satish C. Kalhan | 2016-08-09 |
| 9365889 | PON1 as a marker for heart failure | — | 2016-06-14 |
| 9365888 | Assessing the risk of a major adverse cardiac event in patients with chest pain | Renliang Zhang | 2016-06-14 |
| 9265736 | Treatment of cardiovascular disease and thrombosis | Zeneng Wang | 2016-02-23 |
| 9170260 | Myeloperoxidase, a risk indicator for cardiovascular disease | Renliang Zhang | 2015-10-27 |
| 9168233 | Treatment and prevention of cardiovascular disease and thrombosis | Bruce S. Levison, Zeneng Wang | 2015-10-27 |
| 9164095 | Myeloperoxidase, a risk indicator for cardiovascular disease | Renliang Zhang | 2015-10-20 |
| 9140703 | Combined F2-isoprostane and myeloperoxidase detection, a risk indicator for cardiovascular disease | Renliang Zhang | 2015-09-22 |
| 9086425 | Carbamylated proteins and risk of cardiovascular disease | Zeneng Wang | 2015-07-21 |
| 9051393 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Jonathan Smith | 2015-06-09 |
| 9005904 | Risk markers for cardiovascular disease | Michael Kinter, Marc S. Penn, Jonathan Smith, Lemin Zheng | 2015-04-14 |
| 8722344 | Risk markers for cardiovascular disease | Michael Kinter, Marc S. Penn, Jonathan Smith, Lemin Zheng | 2014-05-13 |
| 8628935 | PON1 as a marker for heart failure | — | 2014-01-14 |
| 8536117 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Jonathan Smith | 2013-09-17 |
| 8349581 | Assessing the risk of a major adverse cardiac event in patients with chest pain | Marc S. Penn, Renliang Zhang | 2013-01-08 |
| 8338110 | Risk markers for cardiovascular disease | Michael Kinter, Marc S. Penn, Jonathan Smith, Lemin Zheng | 2012-12-25 |
| 8309320 | Diagnosis of conditions associated with decreased arginine bioavailability | Claudia R. Morris | 2012-11-13 |
| 8143224 | Oxidant resistant apolipoprotein A-1 and mimetic peptides | Jonathan Smith | 2012-03-27 |
| 7780950 | Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents | — | 2010-08-24 |